alendronate has been researched along with triiodothyronine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Affinito, P; Arlotta, F; Cascone, E; Di Carlo, C; Lupoli, G; Nappi, C; Nuzzo, V; Vitale, G; Vollery, M | 1 |
Bentz, B; Bray, GA; Browndyke, J; Gouvier, WD; Hammer, JH; Hilsabeck, RC; Lovejoy, JC; Pinkston, JB; Santa Maria, MP; Smiroldo, B; Smith, SR | 1 |
1 review(s) available for alendronate and triiodothyronine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for alendronate and triiodothyronine
Article | Year |
---|---|
Neuropsychological and emotional changes during simulated microgravity: effects of triiodothyronine alendronate, and testosterone.
Topics: Adult; Alendronate; Cognition; Emotions; Female; Head-Down Tilt; Humans; Male; Middle Aged; Neuropsychological Tests; Testosterone; Time Factors; Triiodothyronine; Weightlessness Countermeasures; Weightlessness Simulation | 2004 |
2 other study(ies) available for alendronate and triiodothyronine
Article | Year |
---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole.
Topics: Adult; Alendronate; Bone Density; Female; Humans; Hyperthyroidism; Methimazole; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Thyrotropin; Thyroxine; Triiodothyronine | 1996 |